Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.3B | 13.7B | 13.9B | 14.0B |
Cost of revenue | 7.0B | 10.0B | 7.6B | 8.0B |
Gross profit | 6.4B | 3.6B | 6.3B | 6.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 448M | 9.7B | 484M | 438M |
Other operating expenses | 3.6B | -7.9B | 3.2B | 3.3B |
Operating income | 2.4B | 1.8B | 2.6B | 2.3B |
Non operating interest income | ||||
Income | 1M | — | 111M | 68M |
Expense | 175M | 181M | 145M | 187M |
Other income expense | 114M | -534M | 238M | 82M |
Pretax income | 2.3B | 1.1B | 2.7B | 2.2B |
Tax provision | 601M | 272M | 674M | 615M |
Net income | 1.7B | 818M | 2.0B | 1.6B |
Basic EPS | 1.4 | 0.7 | 1.6 | 1.2 |
Diluted EPS | 1.4 | 0.7 | 1.6 | 1.2 |
Basic average shares | 1.2B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.2B | 1.3B | 1.3B | 1.3B |
EBITDA | 4.0B | 3.7B | 4.4B | 4.0B |
Net income from continuing op. | 1.7B | 818M | 2.0B | 1.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |